The FTC announced a proposed consent agreement with Caremark and Zinc Health Services addressing formulary design, point-of-sale rebates, fee structures, plan-sponsor transparency, community-pharmacy reimbursement, and access to pharmacy hub services.
Records announced remedy terms in the pending administrative matter. The filing does not establish realized savings, changes in PBM market structure, or a basis for calculating the withheld market HHI.
Exact named-organization edges
Remedy subject
Caremark Rx, LLCPharmacy benefit manager named in FTC study and administrative complaint records.
Source-specific evidence
The FTC settlement announcement identifies Caremark among the entities subject to the proposed consent agreement.
Remedy subject
Zinc Health Services, LLCGroup purchasing organization named in the FTC insulin administrative complaint record.
Source-specific evidence
The FTC settlement announcement identifies affiliated group purchasing organization Zinc Health Services among the entities subject to the proposed consent agreement.
A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.
Descriptive economic context
Each row searches one linked market profile for strict pre-event, same-year, and strict post-event observations. Missing anchors remain part of the result.
Before/after HHI differences are descriptive comparisons between discrete public releases. They do not estimate the causal effect of the policy event.
Bounded market context
United States / Health care
HHI unavailablePharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.
A linked market identifies the observatory context assigned to this record. It is not necessarily the relevant antitrust market alleged or adjudicated in the official matter.
Source custody
Federal Trade Commission / agency report
FTC announcement and proposed consent-order record resolving the administrative action against Caremark and Zinc Health Services.
Accessed Jul 20, 2026. Federal Trade Commission, FTC Secures Major Settlement with Caremark Resolving Antitrust Case Against Second Drug Middleman, July 14 2026.
License note: Public federal government record
Nearby observatory chronology
Explicit proceeding membership / record 3 of 3
Open the declared chronology before using market-linked nearby records as broader context.
Feb 4, 2026
RemedyFederal Trade Commission
FTC announces proposed consent agreement with Express ScriptsShared context: PBMs
Sep 20, 2024
LitigationFederal Trade Commission
FTC files administrative complaint against the three largest PBMsShared context: PBMs
Jul 9, 2024
MonitoringFederal Trade Commission
FTC releases interim staff report on prescription drug middlemenShared context: PBMs
This chronology is generated from shared observatory market links. It does not assert that the records concern the same matter, conduct, parties, or theory of harm.
Reproducible record packet
Filtered routes preserve the exact event ID across the official record, named-organization edges, descriptive market windows, and linked market profiles.
A record dossier preserves what one dated official source says and the observatory context linked to it. It does not convert allegations into findings, findings into economy-wide conclusions, or nearby market indicators into causal effects.
A linked market identifies the observatory context assigned to this record. It is not necessarily the relevant antitrust market alleged or adjudicated in the official matter.